top of page

Intravenous Ketamine Plus Neurocognitive Training for Depression

About the study

NCT Trial Number

NCT03237286

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Rebecca Price|National Institute of Mental Health (NIMH)|University of Pittsburgh

noun_date_3237048.png

Trial Start Date

Dec-17

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 60 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

No

This study aims to characterize the effects of intravenous ketamine on correlates of depression and assess the efficacy for treating depression when combining intravenous ketamine with neurocognitive training.

Eyes Graffiti

Locations


United States, Pennsylvania
Western Psychiatric Institute and Clinic

Pittsburgh, Pennsylvania, United States, 15213

Contact: Rebecca B Price, PhD
412-648-6445
canlab@pitt.edu

Contact: Crystal Spotts
4122465764
spottscr@upmc.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page